Attention Relapsed/Refractory Myeloma Patients

If you are a myeloma patient with Relapsed (your disease has progressed) and/or Refractory (you have not responded to initial therapy or have relapsed within six months of initial therapy) disease, and your disease has progressed despite treatment with new therapies like Revlimid and Velcade, there are clinical trials with new treatment options available to you.

By calling 800-506-9044, a trained clinical trials specialist will help you to complete a personalized profile to find trials that are right for you. The service is free and all submitted information is kept strictly confidential. Alternatively, log on to www.MyelomaTrials.org, and complete the profile yourself.

It is important for you to know that you do have options even if you are no longer responding to the latest therapies. And, the more people who participate in clinical trials, the faster critical research questions can be answered that will lead to better treatment options for all patients.